1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Drug R&D Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Peptide Hormones
1.2.3 Hematopoietic Factor
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinase
1.2.7 Fusion Protein
1.2.8 Other
1.3 Market by Application
1.3.1 Global Recombinant Protein Drug R&D Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diabetes
1.3.3 Dwarfism
1.3.4 Hemophilia
1.3.5 Heart Disease
1.3.6 Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Recombinant Protein Drug R&D Market Perspective (2017-2028)
2.2 Recombinant Protein Drug R&D Growth Trends by Region
2.2.1 Recombinant Protein Drug R&D Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Recombinant Protein Drug R&D Historic Market Size by Region (2017-2022)
2.2.3 Recombinant Protein Drug R&D Forecasted Market Size by Region (2023-2028)
2.3 Recombinant Protein Drug R&D Market Dynamics
2.3.1 Recombinant Protein Drug R&D Industry Trends
2.3.2 Recombinant Protein Drug R&D Market Drivers
2.3.3 Recombinant Protein Drug R&D Market Challenges
2.3.4 Recombinant Protein Drug R&D Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Drug R&D Players by Revenue
3.1.1 Global Top Recombinant Protein Drug R&D Players by Revenue (2017-2022)
3.1.2 Global Recombinant Protein Drug R&D Revenue Market Share by Players (2017-2022)
3.2 Global Recombinant Protein Drug R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Protein Drug R&D Revenue
3.4 Global Recombinant Protein Drug R&D Market Concentration Ratio
3.4.1 Global Recombinant Protein Drug R&D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Drug R&D Revenue in 2021
3.5 Recombinant Protein Drug R&D Key Players Head office and Area Served
3.6 Key Players Recombinant Protein Drug R&D Product Solution and Service
3.7 Date of Enter into Recombinant Protein Drug R&D Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Recombinant Protein Drug R&D Breakdown Data by Type
4.1 Global Recombinant Protein Drug R&D Historic Market Size by Type (2017-2022)
4.2 Global Recombinant Protein Drug R&D Forecasted Market Size by Type (2023-2028) 5 Recombinant Protein Drug R&D Breakdown Data by Application
5.1 Global Recombinant Protein Drug R&D Historic Market Size by Application (2017-2022)
5.2 Global Recombinant Protein Drug R&D Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Recombinant Protein Drug R&D Market Size (2017-2028)
6.2 North America Recombinant Protein Drug R&D Market Size by Type
6.2.1 North America Recombinant Protein Drug R&D Market Size by Type (2017-2022)
6.2.2 North America Recombinant Protein Drug R&D Market Size by Type (2023-2028)
6.2.3 North America Recombinant Protein Drug R&D Market Share by Type (2017-2028)
6.3 North America Recombinant Protein Drug R&D Market Size by Application
6.3.1 North America Recombinant Protein Drug R&D Market Size by Application (2017-2022)
6.3.2 North America Recombinant Protein Drug R&D Market Size by Application (2023-2028)
6.3.3 North America Recombinant Protein Drug R&D Market Share by Application (2017-2028)
6.4 North America Recombinant Protein Drug R&D Market Size by Country
6.4.1 North America Recombinant Protein Drug R&D Market Size by Country (2017-2022)
6.4.2 North America Recombinant Protein Drug R&D Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada 7 Europe
7.1 Europe Recombinant Protein Drug R&D Market Size (2017-2028)
7.2 Europe Recombinant Protein Drug R&D Market Size by Type
7.2.1 Europe Recombinant Protein Drug R&D Market Size by Type (2017-2022)
7.2.2 Europe Recombinant Protein Drug R&D Market Size by Type (2023-2028)
7.2.3 Europe Recombinant Protein Drug R&D Market Share by Type (2017-2028)
7.3 Europe Recombinant Protein Drug R&D Market Size by Application
7.3.1 Europe Recombinant Protein Drug R&D Market Size by Application (2017-2022)
7.3.2 Europe Recombinant Protein Drug R&D Market Size by Application (2023-2028)
7.3.3 Europe Recombinant Protein Drug R&D Market Share by Application (2017-2028)
7.4 Europe Recombinant Protein Drug R&D Market Size by Country
7.4.1 Europe Recombinant Protein Drug R&D Market Size by Country (2017-2022)
7.4.2 Europe Recombinant Protein Drug R&D Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Drug R&D Market Size (2017-2028)
8.2 Asia-Pacific Recombinant Protein Drug R&D Market Size by Type
8.2.1 Asia-Pacific Recombinant Protein Drug R&D Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Recombinant Protein Drug R&D Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Recombinant Protein Drug R&D Market Share by Type (2017-2028)
8.3 Asia-Pacific Recombinant Protein Drug R&D Market Size by Application
8.3.1 Asia-Pacific Recombinant Protein Drug R&D Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Recombinant Protein Drug R&D Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Recombinant Protein Drug R&D Market Share by Application (2017-2028)
8.4 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region
8.4.1 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Recombinant Protein Drug R&D Market Size (2017-2028)
9.2 Latin America Recombinant Protein Drug R&D Market Size by Type
9.2.1 Latin America Recombinant Protein Drug R&D Market Size by Type (2017-2022)
9.2.2 Latin America Recombinant Protein Drug R&D Market Size by Type (2023-2028)
9.2.3 Latin America Recombinant Protein Drug R&D Market Share by Type (2017-2028)
9.3 Latin America Recombinant Protein Drug R&D Market Size by Application
9.3.1 Latin America Recombinant Protein Drug R&D Market Size by Application (2017-2022)
9.3.2 Latin America Recombinant Protein Drug R&D Market Size by Application (2023-2028)
9.3.3 Latin America Recombinant Protein Drug R&D Market Share by Application (2017-2028)
9.4 Latin America Recombinant Protein Drug R&D Market Size by Country
9.4.1 Latin America Recombinant Protein Drug R&D Market Size by Country (2017-2022)
9.4.2 Latin America Recombinant Protein Drug R&D Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Drug R&D Market Size (2017-2028)
10.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type
10.2.1 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Recombinant Protein Drug R&D Market Share by Type (2017-2028)
10.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application
10.3.1 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Recombinant Protein Drug R&D Market Share by Application (2017-2028)
10.4 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country
10.4.1 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Recombinant Protein Drug R&D Introduction
11.1.4 Eli Lilly Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.1.5 Eli Lilly Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Recombinant Protein Drug R&D Introduction
11.2.4 Novo Nordisk Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.2.5 Novo Nordisk Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Recombinant Protein Drug R&D Introduction
11.3.4 Amgen Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.3.5 Amgen Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Recombinant Protein Drug R&D Introduction
11.4.4 Merck Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.4.5 Merck Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Recombinant Protein Drug R&D Introduction
11.5.4 Sanofi Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Recombinant Protein Drug R&D Introduction
11.6.4 Pfizer Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Recombinant Protein Drug R&D Introduction
11.7.4 Roche Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.7.5 Roche Recent Developments
11.8 Gensci
11.8.1 Gensci Company Details
11.8.2 Gensci Business Overview
11.8.3 Gensci Recombinant Protein Drug R&D Introduction
11.8.4 Gensci Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.8.5 Gensci Recent Developments
11.9 Ankebio
11.9.1 Ankebio Company Details
11.9.2 Ankebio Business Overview
11.9.3 Ankebio Recombinant Protein Drug R&D Introduction
11.9.4 Ankebio Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.9.5 Ankebio Recent Developments
11.10 United Cell
11.10.1 United Cell Company Details
11.10.2 United Cell Business Overview
11.10.3 United Cell Recombinant Protein Drug R&D Introduction
11.10.4 United Cell Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.10.5 United Cell Recent Developments
11.11 Sinobioway Hygene
11.11.1 Sinobioway Hygene Company Details
11.11.2 Sinobioway Hygene Business Overview
11.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Introduction
11.11.4 Sinobioway Hygene Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.11.5 Sinobioway Hygene Recent Developments
11.12 Kexing
11.12.1 Kexing Company Details
11.12.2 Kexing Business Overview
11.12.3 Kexing Recombinant Protein Drug R&D Introduction
11.12.4 Kexing Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.12.5 Kexing Recent Developments
11.13 Dongbao
11.13.1 Dongbao Company Details
11.13.2 Dongbao Business Overview
11.13.3 Dongbao Recombinant Protein Drug R&D Introduction
11.13.4 Dongbao Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.13.5 Dongbao Recent Developments
11.14 3sbio
11.14.1 3sbio Company Details
11.14.2 3sbio Business Overview
11.14.3 3sbio Recombinant Protein Drug R&D Introduction
11.14.4 3sbio Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.14.5 3sbio Recent Developments
11.15 Gan&Lee
11.15.1 Gan&Lee Company Details
11.15.2 Gan&Lee Business Overview
11.15.3 Gan&Lee Recombinant Protein Drug R&D Introduction
11.15.4 Gan&Lee Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.15.5 Gan&Lee Recent Developments
11.16 Hengrui
11.16.1 Hengrui Company Details
11.16.2 Hengrui Business Overview
11.16.3 Hengrui Recombinant Protein Drug R&D Introduction
11.16.4 Hengrui Revenue in Recombinant Protein Drug R&D Business (2017-2022)
11.16.5 Hengrui Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
